An exploration of the feasibility of a randomised clinical trial for physiotherapy intervention in patients at high risk of early-onset knee osteoarthritis and symptomatic decline following anterior cruciate ligament reconstruction.

Professor Kay Crossley0 个研究点目标入组 24 人开始时间: 2016年5月2日最近更新: 2020年1月13日

研究概览

暂无简介。

•(i) aged 18-50 years; (ii) primary arthroscopic ACLR with a hamstring-tendon autograft 6 months prior; (iii) evidence of poor knee function at 12 months as defined by:
•< 87.5 on KOOS-QoL score AND meeting one the following three criteria:
•1. <22 on the one leg rise task OR
•2. <88% LSI on single leg hop for distance
•3. <87 on the AKP scale
•Please note that patients will be recruited at 6 months post ACLR into a recruitment pool. From this point we will monitor their activity level from 6 -12 months as it has been shown significant bone and cartilage changes occur in this time point, and it has been suggested that those that participate early in cutting/impact activities may have greater changes. At 12 months, each patient who had agreed to be contacted for eligibility at 12 months will be re contacted, The patients will then be invited to attend an eligibility testing session at BodySystem clinic, of which the KOOS- QoL, one leg rise, single hop for distance and AKP scale will be administered by a physiotherapist who will not be involved in the treatment intervention. If eligible they will book an appointment for physiotherapy 1:1 session, to begin as soon as possible.
•Note: The patients will be informed on the possibility at 6 months that they may not be eligible for the study.

•(i) previous injury/symptoms in the ACL injured knee; (ii) >5 years between ACL injury and reconstruction; (iii) subsequent injury (for which medical treatment was sought) or follow-up surgery to the ACLR knee; (v) another condition influencing daily function; (iv) inability to understand written and spoken English.

发起方

Professor Kay Crossley